David Schnell April 17, 2018 April 14, 2018 - NGM Bio Announces Results From Phase 2 Study Of NGM282 In NASH Patients Demonstrating Clinically Significant Improvements In Liver Histology After 12 Weeks David Schnell April 17, 2018